(18)F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial

INTRODUCTION: We used phase-3 CONVERT trial data to investigate the impact of fludeoxyglucose F 18 ((18)F-FDG) positron emission tomography (PET)/computed tomography (CT) in SCLC. METHODS: CONVERT randomized patients with limited-stage SCLC to twice-daily (45 Gy in 30 fractions) or once-daily (66 Gy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Oncol
Autors principals: Manoharan, Prakash, Salem, Ahmed, Mistry, Hitesh, Gornall, Michael, Harden, Susan, Julyan, Peter, Locke, Imogen, McAleese, Jonathan, McMenemin, Rhona, Mohammed, Nazia, Snee, Michael, Woods, Sarah, Westwood, Thomas, Faivre-Finn, Corinne
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616906/
https://ncbi.nlm.nih.gov/pubmed/31002954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.03.023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars